EGFR-targeted drugs and resistance mechanisms in non–small cell lung cancer: Molecular insights and emerging therapeutic strategies
Year: 2026
Type: review
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR, non-small cell lung cancer, EGFR mutation, tyrosine kinase inhibitors, drug resistance, T790M, C797S, exon 19 deletion, L858R, exon 20 insertion, bypass signaling, combination therapy, MEK inhibitors, MET inhibitors, AXL inhibitor, bispecific antibodies, antibody-drug conjugates, immunomodulation, nanotechnology drug delivery, liquid biopsy, circulating tumor DNA, precision oncology
Open Access status: green
OpenAlex ID: W7225639624
